ConductScience.org, home

Paper39737640

JAK inhibition decreases the autoimmune burden in Down syndrome.

Rachubinski AL and 21 others. Elife, 2024. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. JAK inhibition decreases the autoimmune burden in Down syndrome. Papers, record 39737640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39737640

Download JSON
Disease
atopic eczema238 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
JAK inhibition decreases the autoimmune burden in Down syndrome.
PubMed
Journal
Elife
PubMed
Year
2024
PubMed
Publication types
Journal Article, Clinical Trial, Phase II
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
5.65, provisional
iCite
Revised in PubMed
2026-03-07
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rachubinski ALAngela L
2Wallace EElizabeth
3Gurnee EEmily
4Enriquez-Estrada BABelinda A
5Worek KRKayleigh R
6Smith KPKeith P
7Araya PPaula
8Waugh KAKatherine A
9Granrath RERoss E
10Britton EEleanor
11Lyford HRHannah R
12Donovan MGMicah G
13Eduthan NPNeetha Paul
14Hill AAAmanda A
15Martin BBarry
16Sullivan KDKelly Dhttps://orcid.org/0000-0003-2725-0205
17Patel LLina
18Fidler DJDeborah J
19Galbraith MDMatthew Dhttps://orcid.org/0000-0003-0485-3927
20Dunnick CACory A

Source PubMed

See all 22 authorsDownload CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Down SyndromeMajor topic
Janus Kinase InhibitorsMajor topic
PiperidinesMajor topic
PyrimidinesMajor topic
Adolescent
Adult
Child
Child, Preschool
Female
Humans
Infant
Male
Young Adult
Autoantibodies
Autoimmunity
Cytokines
Pyrroles
Middle Aged

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI150305NIAID NIH HHSUnited StatesR01AI150305PubMed and NIHNIH RePORTER
R61AR077495NIAMS NIH HHSUnited StatesR61AR077495PubMed and NIHNIH RePORTER
R01AI150305National Institute of Allergy and Infectious DiseasesR01AI150305PubMed and NIHNIH RePORTER
P30 CA046934NCI NIH HHSUnited StatesP30CA046934PubMed and NIHNIH RePORTER
T32CA190216NCI NIH HHSUnited StatesT32CA190216PubMed and NIHNIH RePORTER
R61 AR077495NIAMS NIH HHSUnited StatesR61AR077495PubMed and NIHNIH RePORTER
UM1 TR004399NCATS NIH HHSUnited StatesUM1TR004399PubMed and NIHNIH RePORTER
2T32AR007411-31NIAMS NIH HHSUnited StatesT32AR007411PubMed and NIHNIH RePORTER
R33 AR077495NIAMS NIH HHSUnited StatesR61AR077495PubMed and NIHNIH RePORTER
T32 AR007411NIAMS NIH HHSUnited StatesT32AR007411PubMed and NIHNIH RePORTER
T32 CA190216NCI NIH HHSUnited StatesT32CA190216PubMed and NIHNIH RePORTER
UM1TR004399NCATS NIH HHSUnited StatesUM1TR004399PubMed and NIHNIH RePORTER
P30CA046934NCI NIH HHSUnited StatesP30CA046934PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04246372Tofacitinib for Immune Skin Conditions in Down SyndromeDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of38946973

Source PubMed

Download CSV of comments and corrections

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116901300Dermatological manifestations of Down's syndrome.Clin Exp Dermatol2006https://conductscience.org/library/papers/16901300PubMed
225612231Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm.Nat Protoc2015https://conductscience.org/library/papers/25612231PubMed
333630031JAK inhibition for treatment of psoriatic arthritis in Down syndrome.Rheumatology (Oxford)2021https://conductscience.org/library/papers/33630031PubMed
436813963Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells.Nature2023https://conductscience.org/library/papers/36813963PubMed
523275362Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in Down syndrome.Diabetes Care2013https://conductscience.org/library/papers/23275362PubMed
639327647Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes.Pediatr Dermatol2024https://conductscience.org/library/papers/39327647PubMed
733093664Immune-mediated necrotizing myopathy: clinical features and pathogenesis.Nat Rev Rheumatol2020https://conductscience.org/library/papers/33093664PubMed
818929686Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform2009https://conductscience.org/library/papers/18929686PubMed
933329559MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors.Front Immunol2020https://conductscience.org/library/papers/33329559PubMed
1019358741flowCore: a Bioconductor package for high throughput flow cytometry.BMC Bioinformatics2009https://conductscience.org/library/papers/19358741PubMed
1124860174Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.J Physiol2014https://conductscience.org/library/papers/24860174PubMed
1237147460Down syndrome: insights into autoimmune mechanisms.Nat Rev Rheumatol2023https://conductscience.org/library/papers/37147460PubMed
1325011431Ten-year longitudinal study of thyroid function in children with Down's syndrome.Horm Res Paediatr2014https://conductscience.org/library/papers/25011431PubMed
149710446Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.J Clin Invest1998https://conductscience.org/library/papers/9710446PubMed
1529093484Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.Sci Rep2017https://conductscience.org/library/papers/29093484PubMed
1637360690Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling.iScience2023https://conductscience.org/library/papers/37360690PubMed
1729633736Thyroid Disorders in Subjects with Down Syndrome: An Update.Acta Biomed2018https://conductscience.org/library/papers/29633736PubMed
1837277650Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.Nat Genet2023https://conductscience.org/library/papers/37277650PubMed
1932705346Down syndrome, accelerated aging and immunosenescence.Semin Immunopathol2020https://conductscience.org/library/papers/32705346PubMed
2028259872Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome .Horm Res Paediatr2017https://conductscience.org/library/papers/28259872PubMed

See all 83 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42824469JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions.Drug Des Devel Ther2026https://conductscience.org/library/papers/42824469PubMed
42678586Immune Dysregulation in Down Syndrome: Implications for Infectious Susceptibility and Vaccine Response.J Clin Immunol2026https://conductscience.org/library/papers/42678586PubMed
42638456Fasudil induces anti-inflammatory transcriptomic changes and increased proliferation in human trisomy 21 neural progenitor cells.Biol Open2026https://conductscience.org/library/papers/42638456PubMed
42620150Progressive deterioration of adaptive immune repertoires in Down syndrome linked to interferon hyperactivity and lymphoid tissue disorganization.bioRxiv2026https://conductscience.org/library/papers/42620150PubMed
42496069The Mediator complex: co-transcriptional regulation and beyond.RNA Biol2026https://conductscience.org/library/papers/42496069PubMed
42459548Clinical considerations for immune dysregulation and immunodeficiency in Down syndrome.J Hum Immun2026https://conductscience.org/library/papers/42459548PubMed
42343870Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.Expert Rev Neurother2026https://conductscience.org/library/papers/42343870PubMed
42327181An AI-Powered Trisomy 21 Research Assistant.bioRxiv2026https://conductscience.org/library/papers/42327181PubMed
42317350Revisiting down syndrome through the lens of interferonopathy and innate immune dysregulation.Front Immunol2026https://conductscience.org/library/papers/42317350PubMed
42293324Immunosuppression in down syndrome regression disorder: a prospective observational cohort study.Brain Commun2026https://conductscience.org/library/papers/42293324PubMed
42266045Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.Curr Opin Rheumatol2026https://conductscience.org/library/papers/42266045PubMed
42253980Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.Front Immunol2026https://conductscience.org/library/papers/42253980PubMed
42250043Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society.Neuromolecular Med2026https://conductscience.org/library/papers/42250043PubMed
42169680How I Treat: Immune dysregulation in Down syndrome.J Hum Immun2026https://conductscience.org/library/papers/42169680PubMed
42156776Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities.NPJ Vaccines2026https://conductscience.org/library/papers/42156776PubMed
42115186Systematic multi-omic deconvolution of the clinical heterogeneity of Down syndrome.Nat Commun2026https://conductscience.org/library/papers/42115186PubMed
42092016Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.Pediatr Res2026https://conductscience.org/library/papers/42092016PubMed
41889986Anti-inflammatory and pro-proliferative effects of fasudil in human trisomy 21 neural progenitor cells.bioRxiv2026https://conductscience.org/library/papers/41889986PubMed
41586519The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis.mBio2026https://conductscience.org/library/papers/41586519PubMed
41538324Altered hepatic metabolism in Down syndrome.Cell Rep2026https://conductscience.org/library/papers/41538324PubMed

See all 30 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TOFACITINIBCHEMBL221959Derived from the trial1https://conductscience.org/library/drugs/CHEMBL221959

Source ChEMBL

Download CSV of drugs

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GEOGSE251967GEO
GEOGSE190125GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39737640

GET https://conductscience.org/api/papers/v1/39737640/authors?page=2